CoChat

A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors

Open access
Nikolenko, Galina N., Delviks-Frankenberry, Krista A., Pathak, Vinay K. · 2010 · Journal of Virology

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Abstract

Recently, mutations in the connection subdomain (CN) and RNase H domain of HIV-1 reverse transcriptase (RT) were observed to exhibit dual resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs). To elucidate the mechanism by which CN and RH mutations confer resistance to NNRTIs, we hypothesized that these mutations reduce RNase H cleavage and provide more time for the NNRTI to dissociate from the RT, resulting in the resumption of DNA synthesis and enhanced NNRTI resistance. We observed that the effect of the reduction in RNase H cleavage on NNRTI resistance is dependent upon the affinity of each NNRTI to the RT and further influenced by the presence of NNRTI-binding pocket (BP) mutants. D549N, Q475A, and Y501A mutants, which reduce RNase H cleavage, enhance resistance to nevirapine (NVP) and delavirdine (DLV), but not to efavirenz (EFV) and etravirine (ETR), consistent with their increase in affinity for RT. Combining the D549N mutant with NNRTI BP mutants further increases NNRTI resistance from 3- to 30-fold, supporting the role of NNRTI-RT affinity in our NNRTI resistance model. We also demonstrated that CNs from treatment-experienced patients, previously reported to enhance NRTI resistance, also reduce RNase H cleavage and enhance NNRTI resistance in the context of the patient RT pol domain or a wild-type pol domain. Together, these results confirm key predictions of our NNRTI resistance model and provide support for a unifying mechanism by which CN and RH mutations can exhibit dual NRTI and NNRTI resistance.

Overview

Integrity signals

Registry

Crossref · 10.1128/jvi.01545-09

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Research works printed but not linked: 3

  1. Nikolenko, G. N., K. A. Delviks-Frankenberry, A. Jere, and V. K. Pathak. 2008. Mutations in the reverse transcriptase connection and RNase H domains exhibit dual resistance to nucleoside and non-nucleoside reverse transcriptase inhibitors. Antivir. Ther.13:A55-A55.
  2. Sharma, S. K., N. Fan, K. B. Rank, L. A. Kopta, R. A. Olmsted, S. M. Poppe, D. E. Slade, R. C. Thomas, and W. G. Tarpley. 1995. A drug-resistance mutation (G190E) in the inhibitor binding pocket impairs both RNA-dependent DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase. J. Acquir. Immune Defic. Syndr. Hum. Retrovir.10:2.
  3. 10.1021/bi952058 · doi:10.1021/bi952058

Cited by

See all 56

Metadata

Authors
Nikolenko, G. N., Delviks-Frankenberry, K. A., & Pathak, V. K.
Affiliations
  • Frederick National Laboratory for Cancer Research (US)
  • Viral Mutation Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland 21702
Corresponding author
Pathak, Vinay K.
Venue
Journal of Virology
Published
2010-05-15
Volume
84
Issue
10
Pages
5238-5249
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2018143554
Cited by
47
References
58
Citations by year
2026: 1 · 2025: 1 · 2021: 3 · 2020: 1 · 2017: 3 · 2016: 1 · 2015: 6 · 2014: 3 · 2013: 7 · 2012: 6
FWCI
5.58
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (ZIABC010532)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
HIV-1 reverse transcriptase, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, RNase H cleavage, nevirapine, delavirdine, efavirenz, etravirine, drug binding affinity, treatment-experienced patients
MeSH terms
Humans, HIV-1, Ribonuclease H, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Mutation, Missense, Drug Resistance, Viral, HIV Reverse Transcriptase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors. https://app.cochat.ai/papers/10.1128/jvi.01545-09
The paper
Nikolenko, G. N., Delviks-Frankenberry, K. A., & Pathak, V. K. (2010). A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors. Journal of Virology. https://doi.org/10.1128/jvi.01545-09

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.